MedTrace Logo

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

NCT05752448 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-03

No results posted yet for this study

Summary

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Conditions

  • Ovarian Neoplasm
  • Depressive Symptoms
  • Quality of Life

Interventions

BEHAVIORAL

POSTCare Survivorship transition process

Survivorship coaching intervention

Sponsors & Collaborators

  • Cancer Prevention Research Institute of Texas

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • University of Texas at Austin

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Elizabeth Kvale, MD,MPH · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2026-07-01
Completion
2027-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752448 on ClinicalTrials.gov